5-Azacytidine (NSC 102816) in refractory germ cell tumors - A phase II trial of the Eastern Cooperative Oncology Group

Bruce J. Roth; Paul Elson; George W. Sledge; Lawrence H. Einhorn; Donald L. Trump

doi:10.1007/BF00874155

5-Azacytidine (NSC 102816) in refractory germ cell tumors - A phase II trial of the Eastern Cooperative Oncology Group

Bruce J. Roth, Paul Elson, George W. Sledge, Lawrence H. Einhorn, Donald L. Trump

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	201-202
Number of pages	2
Journal	Investigational New Drugs
Volume	11
Issue number	2-3
DOIs	https://doi.org/10.1007/BF00874155
State	Published - Jun 1993

Keywords

5-azacytidine
cisplatin-refractory
germ cell tumors
testicular cancer

Access to Document

10.1007/BF00874155

Cite this

@article{24cd7c6cd6e841b0be2155bf457878d9,

title = "5-Azacytidine (NSC 102816) in refractory germ cell tumors - A phase II trial of the Eastern Cooperative Oncology Group",

keywords = "5-azacytidine, cisplatin-refractory, germ cell tumors, testicular cancer",

author = "Roth, {Bruce J.} and Paul Elson and Sledge, {George W.} and Einhorn, {Lawrence H.} and Trump, {Donald L.}",

year = "1993",

month = jun,

doi = "10.1007/BF00874155",

language = "English",

volume = "11",

pages = "201--202",

journal = "Investigational New Drugs",

issn = "0167-6997",

number = "2-3",

}

TY - JOUR

T1 - 5-Azacytidine (NSC 102816) in refractory germ cell tumors - A phase II trial of the Eastern Cooperative Oncology Group

AU - Roth, Bruce J.

AU - Elson, Paul

AU - Sledge, George W.

AU - Einhorn, Lawrence H.

AU - Trump, Donald L.

PY - 1993/6

Y1 - 1993/6

KW - 5-azacytidine

KW - cisplatin-refractory

KW - germ cell tumors

KW - testicular cancer

UR - http://www.scopus.com/inward/record.url?scp=0027218560&partnerID=8YFLogxK

U2 - 10.1007/BF00874155

DO - 10.1007/BF00874155

M3 - Article

C2 - 7505269

AN - SCOPUS:0027218560

SN - 0167-6997

VL - 11

SP - 201

EP - 202

JO - Investigational New Drugs

JF - Investigational New Drugs

IS - 2-3

ER -

5-Azacytidine (NSC 102816) in refractory germ cell tumors - A phase II trial of the Eastern Cooperative Oncology Group

Keywords

Access to Document

Other files and links

Cite this